Using HER2-amplified GC cell lines, we demonstrated that T-DXd treatment upregulated PD-L1 at the transcriptional level and enhanced the surface retention of PD-L1 (Fig. 2B and C). The gene discussed is ERBB2; the disease is gastric cancer.